Inhibition of Inflammation-induced Pancreatic Beta-Cell Failure by Targeting the MAP3 Kinase Tpl2: A Potential New Immunotherapy for Type 2 Diabetes

Details

Request a copyRequest a copy
Serval ID
serval:BIB_9082304BDE33
Type
Inproceedings: an article in a conference proceedings.
Publication sub-type
Abstract (Abstract): shot summary in a article that contain essentials elements presented during a scientific conference, lecture or from a poster.
Collection
Publications
Institution
Production externe
Title
Inhibition of Inflammation-induced Pancreatic Beta-Cell Failure by Targeting the MAP3 Kinase Tpl2: A Potential New Immunotherapy for Type 2 Diabetes
Title of the conference
Diabetes
Author(s)
Varin E., Muller D., Broca C., Ravier M., Ceppo F., Renard E., Wojtusciszyn A., Tanti J. F., Dalle S.
ISSN
0012-1797
Publication state
Published
Issued date
06/2015
Volume
64
Pages
A575-A575
Language
english
Web of science
000359482703007
Create date
14/06/2021 8:59
Last modification date
24/05/2024 12:14
Usage data